{"id":508759,"date":"2021-07-01T08:03:47","date_gmt":"2021-07-01T12:03:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/"},"modified":"2021-07-01T08:03:47","modified_gmt":"2021-07-01T12:03:47","slug":"solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/","title":{"rendered":"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">\n        <em>-Additional expertise expected to support attainment of key corporate goals-<\/em>\n      <\/p>\n<p align=\"left\">CAMBRIDGE, Mass., July  01, 2021  (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the hiring of Roxana Donisa Dreghici, M.D. as Senior Vice President, Clinical Development, Caitlin Lowie as Vice President, Communications &amp; IR and Alison Kessler as Vice President, Legal Corporate &amp; IP.<\/p>\n<p>\u201cThe addition of Roxana, Caitlin and Alison brings a tremendous amount of industry experience and passion to our management team,\u201d said Ilan Ganot, Co-Founder, President and Chief Executive Officer of Solid Biosciences. \u201cWe continue to strengthen the leadership team at Solid Biosciences as we look to continue progressing our product pipeline and supporting the Duchenne community.\u201d<\/p>\n<p>Dr. Donisa Dreghici is a seasoned clinical development professional in the pharmaceutical industry having worked across multiple indications with a strong focus on Duchenne and Spinal Muscular Atrophy. Most recently she was the Global Development Lead\/Associate Group Medical Director, Neuroscience for F. Hoffmann La Roche in Basel, Switzerland. She has gained valuable experience serving in investigator and scientific leadership roles at F. Hoffmann La Roche, Santhera, Novartis, Novo Nordisk and Quintiles. Dr. Donisa Greghici will lead all clinical development activities\u00a0at Solid Biosciences.<\/p>\n<p>Ms. Lowie was most recently Senior Director, Communications and Strategic Growth Initiatives at Stallergenes Greer. In her role at Solid Biosciences, Ms. Lowie will lead the development, implementation and execution of an integrated and innovative IR strategy. Additionally, she will be responsible for the corporate communications strategy, ensuring alignment with the overall corporate strategy and IR goals.<\/p>\n<p>Ms. Kessler is an experienced life sciences attorney who has held senior legal roles with several peers including Cosette, Convatec and Novartis. She joined Solid Biosciences as interim general counsel in November 2020. In her new role with the Company, Ms. Kessler will be responsible for\u00a0providing\u00a0strategic advice\u00a0on\u00a0matters related to Solid\u2019s\u00a0IP portfolio, business development endeavors, and a variety of other contracting and corporate matters.\u00a0<\/p>\n<p>\n        <strong>About Solid Biosciences<\/strong><br \/>\n        <br \/>Solid Biosciences is a life sciences company focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Disease-focused and founded by a family directly impacted by Duchenne, our mandate is simple yet comprehensive \u2013 work to address the disease at its core by correcting the underlying mutation that causes Duchenne with our lead gene therapy candidate, SGT-001. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fNyvQo8CGbIuMfD9gBnez9lHItN4bMscMriyIccnSGxzPA3wF7vpssgqkhIykX2FCr3XDgPnusEtKEhvS-bJXg==\" rel=\"nofollow noopener\" target=\"_blank\">www.solidbio.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>David Carey<br \/>FINN Partners<br \/>212-867-1768<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KV5QVwJ1dGb-4GnEVWAr1FOTLdNT54cxTGGsIezepx8gUHf29BOkL4lv43Jw3YoRJbEA0kYAr4PoDIpkBeWoPSD90tRageFdo84S1VrLMymQze8lPo1s-893uivcgvrh\" rel=\"nofollow noopener\" target=\"_blank\">David.Carey@finnpartners.com<\/a><\/p>\n<p>Caitlin Lowie<br \/>Solid Biosciences<br \/>607-423-3219<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xmpwx_uU5EsER_FazyECG8g70NB2402p9Wr4DDsT2fW0onC3ciRhjWeaz42hApogLVcCkMnUIvEW_8rRt5AmF0Cb779U1LZoMVTbBoYCyLyPmCHmnQQ8a4JzTvBoQ1Wo\" rel=\"nofollow noopener\" target=\"_blank\">Clowie@solidbiosciences.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Erich Sandoval<br \/>FINN Partners<br \/>917-497-2867<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MHo1XxRgWcb1XhAu4hVGEhJwsINdYcXQS5OCjgqXvHUhvhvK0kpc0rZ-rxagq_2iLjNQ0qN74lLqfJxLOIxGBq-iq9P9FJ7egIAECN28yxjSY6FbwueblqA6qjfgysz_\" rel=\"nofollow noopener\" target=\"_blank\">Erich.Sandoval@finnpartners.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6080b825-f6bb-4abc-8a2a-f403e95e3eed\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>-Additional expertise expected to support attainment of key corporate goals- CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the hiring of Roxana Donisa Dreghici, M.D. as Senior Vice President, Clinical Development, Caitlin Lowie as Vice President, Communications &amp; IR and Alison Kessler as Vice President, Legal Corporate &amp; IP. \u201cThe addition of Roxana, Caitlin and Alison brings a tremendous amount of industry experience and passion to our management team,\u201d said Ilan Ganot, Co-Founder, President and Chief Executive Officer of Solid Biosciences. \u201cWe continue to strengthen the leadership team at Solid Biosciences as we look to continue progressing our product &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-508759","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"-Additional expertise expected to support attainment of key corporate goals- CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the hiring of Roxana Donisa Dreghici, M.D. as Senior Vice President, Clinical Development, Caitlin Lowie as Vice President, Communications &amp; IR and Alison Kessler as Vice President, Legal Corporate &amp; IP. \u201cThe addition of Roxana, Caitlin and Alison brings a tremendous amount of industry experience and passion to our management team,\u201d said Ilan Ganot, Co-Founder, President and Chief Executive Officer of Solid Biosciences. \u201cWe continue to strengthen the leadership team at Solid Biosciences as we look to continue progressing our product &hellip; Continue reading &quot;Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-01T12:03:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy\",\"datePublished\":\"2021-07-01T12:03:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/\"},\"wordCount\":447,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/\",\"name\":\"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=\",\"datePublished\":\"2021-07-01T12:03:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/","og_locale":"en_US","og_type":"article","og_title":"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy - Market Newsdesk","og_description":"-Additional expertise expected to support attainment of key corporate goals- CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) &#8212; Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the hiring of Roxana Donisa Dreghici, M.D. as Senior Vice President, Clinical Development, Caitlin Lowie as Vice President, Communications &amp; IR and Alison Kessler as Vice President, Legal Corporate &amp; IP. \u201cThe addition of Roxana, Caitlin and Alison brings a tremendous amount of industry experience and passion to our management team,\u201d said Ilan Ganot, Co-Founder, President and Chief Executive Officer of Solid Biosciences. \u201cWe continue to strengthen the leadership team at Solid Biosciences as we look to continue progressing our product &hellip; Continue reading \"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-01T12:03:47+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy","datePublished":"2021-07-01T12:03:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/"},"wordCount":447,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/","name":"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=","datePublished":"2021-07-01T12:03:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzcwMSM0Mjc4MzU1IzIwOTExOTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/solid-biosciences-strengthens-management-team-to-advance-programs-for-duchenne-muscular-dystrophy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Solid Biosciences Strengthens Management Team to Advance Programs for Duchenne Muscular Dystrophy"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/508759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=508759"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/508759\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=508759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=508759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=508759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}